Repare Therapeutics Inc (RPTX)

02:15 AM

Is Repare Therapeutics Inc. forming a reversal patternFree Market Surge Signal for Swing Traders - Newser

02:15 AM

12:44 PM

Backtesting results for Repare Therapeutics Inc. trading strategiesPattern Recognition Based Market Move Prediction - Newser

12:44 PM

Aug 10, 2025

Is Repare Therapeutics Inc. still worth holding after the dipFree AI-Powered Trade Planning with Indicators - Newser

Aug 10, 2025

Aug 10, 2025

Will Repare Therapeutics Inc. benefit from macro trendsDay Trading Plan with Entry Risk Management - Newser

Aug 10, 2025

Aug 10, 2025

Analyzing recovery setups for Repare Therapeutics Inc. investorsFree Smart Trend Trading with Weekly Signals - Newser

Aug 10, 2025

Aug 10, 2025

Repare Therapeutics Reports Q2 2025 Results and Strategic Moves - TipRanks

Aug 10, 2025

Aug 10, 2025

Repare Therapeutics (NASDAQ:RPTX) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Aug 10, 2025

Aug 09, 2025

Repare Therapeutics Reports Q2 Earnings: Strategic Moves and Upcoming Data Releases - AInvest

Aug 09, 2025

Aug 09, 2025

Repare 2025 Q2 Earnings Strong Improvement as Net Loss Narrows 51.8% - AInvest

Aug 09, 2025

Aug 08, 2025

Repare Therapeutics Cuts Losses And Snags New Licensing Deals - Finimize

Aug 08, 2025

Aug 08, 2025

Repare Therapeutics Narrows Losses And Seeks New Paths Forward - Finimize

Aug 08, 2025

Aug 08, 2025

Repare (RPTX) Q2 Loss Narrows 52% - AOL.com

Aug 08, 2025

Aug 08, 2025

Repare Therapeutics' Strategic Shift and Milestone-Driven Outlook - AInvest

Aug 08, 2025

Aug 08, 2025

Repare Therapeutics Announces Licensing Deal and Strategic Updates - TipRanks

Aug 08, 2025

Aug 08, 2025

Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Aug 08, 2025

Aug 08, 2025

Repare Therapeutics reports Q2 EPS (39c) vs. (82c) last year - TipRanks

Aug 08, 2025

Aug 08, 2025

Repare Therapeutics Inc. SEC 10-Q Report - TradingView

Aug 08, 2025

Aug 08, 2025

Repare Therapeutics Q2 net loss narrows to $16.7 mln - MarketScreener

Aug 08, 2025

Aug 08, 2025

Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results | RPTX Stock News - GuruFocus

Aug 08, 2025

Aug 08, 2025

Repare Therapeutics reports Q2 2025 revenue $109.5 mln, cash & marketable securities. - AInvest

Aug 08, 2025

Aug 08, 2025

Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results - The Globe and Mail

Aug 08, 2025

Aug 08, 2025

Predicting Repare Therapeutics Inc. trend using moving averagesChart Scanner for Swing Trade Timing - Newser

Aug 08, 2025

Aug 06, 2025

Is Repare Therapeutics Inc. Stock a Good Fit for Conservative InvestorsSafe Investment Ideas with Growth Upside - Newser

Aug 06, 2025

Aug 06, 2025

Why Repare Therapeutics Inc. stock attracts strong analyst attentionFree Daily Profit Focused Stock Screener - Newser

Aug 06, 2025

Aug 05, 2025

Can Repare Therapeutics Inc. hit a new high this monthFree Low Risk Swing Trade Opportunity List - Newser

Aug 05, 2025

Aug 03, 2025

Quantitative breakdown of Repare Therapeutics Inc. recent movePredicted Market Direction Based on Momentum - Newser

Aug 03, 2025

Aug 03, 2025

What makes Repare Therapeutics Inc. stock price move sharplyUnlock market-leading stock analysis - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Repare Therapeutics Inc. stock in 2025Maximize gains with proven stock analysis - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Repare Therapeutics Inc. Stock Analysis and ForecastAchieve rapid wealth accumulation with smart picks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How volatile is Repare Therapeutics Inc. stock compared to the marketMaximize portfolio value with smart investment plans - Jammu Links News

Aug 03, 2025

Aug 03, 2025

When is Repare Therapeutics Inc. stock expected to show significant growthAmplify your gains with low-risk picks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Does Repare Therapeutics Inc. stock perform well during market downturnsMaximize returns with data-driven strategies - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Repare Therapeutics Inc. a growth stock or a value stockUnlock your portfolio’s hidden potential - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How many analysts rate Repare Therapeutics Inc. as a “Buy”Capitalize on momentum stocks before they peak - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How does Repare Therapeutics Inc. compare to its industry peersCapitalize on fast-moving trading opportunities - Jammu Links News

Aug 03, 2025

Aug 02, 2025

Is Repare Therapeutics Inc. a good long term investmentUnlock powerful market insights for success - Jammu Links News

Aug 02, 2025

Aug 02, 2025

How does Repare Therapeutics Inc. generate profit in a changing economyGet ahead with breakthrough trading ideas - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What are Repare Therapeutics Inc. company’s key revenue driversBuild wealth steadily with proven strategies - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Why is Repare Therapeutics Inc. stock attracting strong analyst attentionInvest in stocks with strong fundamentals - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Repare Therapeutics (RPTX) to Release Quarterly Earnings on Tuesday - MarketBeat

Aug 02, 2025

Aug 02, 2025

Head to Head Comparison: Repare Therapeutics (NASDAQ:RPTX) and Provectus Biopharmaceuticals (OTCMKTS:PVCT) - Defense World

Aug 02, 2025